Merck KGaA is allocating over €300 million ($321.8 million) to build a new research building at its headquarters in Darmstadt ...

Regeneron is expanding its genetic medicine efforts and will work with California startup Mammoth Biosciences on gene-editing ...

Evotec announced a “reset” to its business plan as it reported financial results Wednesday, following a year in which many ...

Roche on Wednesday morning said it has “minor exposure” from the Biosecure Act, adding that it is making strides in China’s ...

Almost 20 biopharma and life sciences companies have registered to lobby on a bill that could ban US companies from working ...

UnitedHealth Group’s Optum is shutting down its virtual care business, Endpoints News has learned. Known as Optum Virtual ...

Cidara Therapeutics announced several sweeping moves on Wednesday afternoon to bring an influenza drug back in-house and ...

Moderna has teamed up with OpenAI to bring its GPT technology to drug development. The collaboration, which a Moderna ...

Freenome, a maker of blood-based cancer tests, will lay off more than 100 employees, or 20% of its workforce, a spokesperson ...

Neurocrine Biosciences’ newly-debuted campaign acknowledges the frustration that congenital adrenal hyperplasia (CAH) ...

Thermo Fisher said it will be a “long-term beneficiary” of biopharma customers localizing their supply chains, given most of ...

Sen. Bernie Sanders (I-VT) is ramping up his campaign against what he says are “outrageously high” list prices for Novo ...